Clinical Trial Update: Notify 2: An Evaluation of the Impact of Notification of Incidental Coronary Artery Calcium on Statin Rates [NA]

View source ↗

Summary

The clinical trial evaluating whether notifying patients about incidental coronary artery calcium influences statin use has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Statins

Snippet

Sponsor: Stanford University | Conditions: Coronary Artery Disease | NA | Status: WITHDRAWN